Please provide your email address to receive an email when new articles are posted on . A single burst of antitachycardia pacing (ATP) reduced risk for shocks in patients with an implantable ...

The first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of ventricular ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Ablation soon after first implantable cardioverter defibrillator shock for ventricular tachycardia ...

Implantable cardioverter-defibrillators (ICDs) are the mainstay of treatment for patients at risk of ventricular tachycardia or fibrillation. Although these devices reduce mortality, defibrillator ...

Combined data from five implantable cardioverter-defibrillator (ICD) trials suggest that it is the underlying arrhythmic disorder, rather than the ICD therapy itself, that affects mortality in these ...

Ventricular tachycardia (VT) ablation should be considered after the first implantable cardioverter defibrillator (ICD) shock in patients with ischemic or nonischemic cardiomyopathy, the PARTITA trial ...

(HealthDay News) — For patients with cardiomyopathy, use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is associated with significantly lower incidence of ...

WASHINGTON -- Researchers made a strong case that earlier was better when it comes to catheter ablation of ventricular tachycardias (VTs) in people with implantable cardiac defibrillators (ICDs).

A case study of a patient who experienced inappropriate shocks from her defibrillator is presented in Heart Rhythm Case Reports, an official journal of the Heart Rhythm Society, published by Elsevier.

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BARCELONA -- The ...